WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus
- 31 January 2007
- journal article
- practice guideline
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 7 (1), 21-31
- https://doi.org/10.1016/s1473-3099(06)70684-3
Abstract
No abstract availableFunding Information
- World Health Organization
This publication has 32 references indexed in Scilit:
- Pandemic influenza: using evidence on vaccines and antivirals for clinical decisions and policy makingEuropean Respiratory Journal, 2006
- Preparing for Pandemic Influenza: Should Hospitals Stockpile Oseltamivir?Infection Control & Hospital Epidemiology, 2005
- Isolation of drug-resistant H5N1 virusNature, 2005
- Evolution of H5N1 Avian Influenza Viruses in AsiaEmerging Infectious Diseases, 2005
- Avian Influenza A (H5N1) Infection in HumansThe New England Journal of Medicine, 2005
- Generation and Characterization of Recombinant Influenza A (H1N1) Viruses Harboring Amantadine Resistance MutationsAntimicrobial Agents and Chemotherapy, 2005
- Grading quality of evidence and strength of recommendationsBMJ, 2004
- Management of Influenza in Households: A Prospective, Randomized Comparison of Oseltamivir Treatment With or Without Postexposure ProphylaxisThe Journal of Infectious Diseases, 2004
- Safety and Pharmacology of Oseltamivir in Clinical UseDrug Safety, 2003
- A Controlled Trial of Amantadine and Rimantadine in the Prophylaxis of Influenza a InfectionThe New England Journal of Medicine, 1982